What is the acute management of paroxysmal supraventricular tachycardia (PSVT)?

Acute Management of Paroxysmal Supraventricular Tachycardia (PSVT)

Begin with vagal maneuvers immediately in hemodynamically stable patients, followed by intravenous adenosine if unsuccessful, and proceed directly to synchronized cardioversion for any hemodynamically unstable patient. 1

Initial Assessment and Hemodynamic Status

First, determine hemodynamic stability by assessing for hypotension, altered mental status, chest pain suggesting ischemia, acute heart failure, or shock. 1 This single determination dictates your entire management pathway and must be made within seconds of patient contact.

Management Algorithm for Hemodynamically Stable Patients

Step 1: Vagal Maneuvers (First-Line)

Perform vagal maneuvers immediately with the patient in the supine position. 1

• Modified Valsalva maneuver: Have the patient bear down against a closed glottis for 10-30 seconds, generating at least 30-40 mm Hg of intrathoracic pressure, with a 43% success rate. 1, 2
• Carotid sinus massage: After confirming absence of carotid bruit by auscultation, apply steady pressure over the right or left carotid sinus for 5-10 seconds (never both simultaneously). 1
• Diving reflex: Apply an ice-cold, wet towel to the face or facial immersion in water at 10°C (50°F). 1
• Switch techniques if first attempt fails: Valsalva is more successful than carotid massage, but switching between techniques achieves an overall 27.7% success rate. 1

Critical pitfall: Never apply pressure to the eyeball—this is dangerous and abandoned. 1

Step 2: Intravenous Adenosine (Second-Line)

If vagal maneuvers fail, administer IV adenosine immediately. 1

• Efficacy: Terminates PSVT in 90-95% of patients with brief side effects (<1 minute) in approximately 30%. 1
• Dosing controversy: Recent evidence suggests starting with 12 mg rather than 6 mg achieves higher conversion rates (54.2% vs. 40.6%, p=0.03). 3 However, traditional guidelines recommend 6 mg initially, followed by 12 mg if needed. 1
• Essential precaution: Have electrical cardioversion equipment immediately available because adenosine may precipitate atrial fibrillation that conducts rapidly to the ventricles, potentially causing ventricular fibrillation. 1
• Post-conversion monitoring: Watch for atrial or ventricular premature complexes that may reinitiate tachycardia, requiring antiarrhythmic drugs to prevent recurrence. 1

Step 3: Alternative Pharmacologic Agents

If adenosine fails or is contraindicated, use IV calcium channel blockers or beta-blockers in hemodynamically stable patients. 1

• IV diltiazem or verapamil: Particularly effective with 80-98% success rates for converting PSVT. 1
• IV beta-blockers: Reasonable alternative with excellent safety profile, though less effective than calcium channel blockers. 1
• Critical contraindications: Do not use diltiazem or verapamil if ventricular tachycardia, pre-excited atrial fibrillation, or systolic heart failure is suspected—these patients may develop ventricular fibrillation or hemodynamic collapse. 1

Important downgrade: The 2019 ESC guidelines downgraded verapamil and diltiazem from their previous recommendations for acute narrow-QRS tachycardias, though they remain reasonable options. 4

Step 4: Synchronized Cardioversion for Refractory Cases

Perform synchronized cardioversion in hemodynamically stable patients when pharmacologic therapy fails or is contraindicated. 1 This is highly effective and performed after adequate sedation or anesthesia. 1

Management for Hemodynamically Unstable Patients

Proceed immediately to synchronized cardioversion if vagal maneuvers or adenosine are ineffective or not feasible. 1

• Rationale: Cardioversion is highly effective and avoids complications of antiarrhythmic drugs in unstable patients. 1
• Timing: Consider early in management—do not delay with multiple pharmacologic attempts. 1
• Post-cardioversion: Monitor for premature complexes that may reinitiate tachycardia, requiring antiarrhythmic prophylaxis. 1

Special Consideration: Pre-Excited Atrial Fibrillation

If the patient has Wolff-Parkinson-White syndrome with pre-excited atrial fibrillation (wide, irregular QRS complexes), the management differs critically:

• Hemodynamically unstable: Immediate synchronized cardioversion. 1
• Hemodynamically stable: Use IV procainamide or ibutilide—never use AV nodal blocking agents (adenosine, calcium channel blockers, beta-blockers, digoxin) as these may enhance accessory pathway conduction and precipitate ventricular fibrillation. 1

Critical Pitfalls to Avoid

• Never use AV nodal blockers in wide-complex tachycardias until ventricular tachycardia is excluded. 1
• Avoid calcium channel blockers and beta-blockers in patients with pre-excitation during atrial fibrillation—they can shorten accessory pathway refractory period and increase ventricular rate. 1
• Do not use digoxin acutely—it is no longer recommended and may enhance accessory pathway conduction. 4
• Ensure cardioversion equipment is available before administering adenosine. 1
• Document vagal maneuver attempts as inconsistent documentation is common. 3

Emerging Therapies

Intranasal etripamil, a self-administered calcium channel blocker, shows promise for out-of-hospital treatment with good tolerability and efficacy, though it is not yet widely available. 5, 6, 7 This represents a potential paradigm shift for recurrent PSVT management but is not currently part of standard acute protocols.